Milestone Pharmaceuticals
MIST • NASDAQ
Milestone Pharmaceuticals is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Joseph G. Oliveto, with a market cap of $122.4M.
CEOJoseph G. Oliveto
Next Earnings
Upcoming earnings announcement for Milestone Pharmaceuticals
Date
Wednesday, May 13, 2026 (in a month)
Timing
Before Market Open (7:00 AM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.13
Revenue Estimate
$75.1M
Earnings History
Past 12 earnings reports for Milestone Pharmaceuticals
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 20, 2026 | Q4 2025 | -$0.16Est: -$0.18 | +11.1% | $1.5MEst: $1.2M | +28.8% |  10-K |
| Nov 12, 2025 | Q3 2025 | -$0.12Est: -$0.17 | +29.4% | -Est: $400.0K | -100.0% | 10-Q |
| Aug 12, 2025 | Q2 2025 | -$0.20Est: -$0.18 | -11.1% | - | — | 10-Q |
| May 14, 2025 | Q1 2025 | -$0.31Est: -$0.19 | -63.2% | - | — | 10-Q |
| Mar 13, 2025 | Q4 2024 | -$0.19Est: -$0.15 | -26.7% | - | — | 10-K |
| Nov 12, 2024 | Q3 2024 | -$0.14Est: -$0.16 | +12.5% | - | — | 10-Q |
| Aug 8, 2024 | Q2 2024 | -$0.14Est: -$0.19 | +26.3% | - | — | 10-Q |
| May 13, 2024 | Q1 2024 | -$0.21Est: -$0.26 | +19.2% | - | — | 10-Q |
| Mar 21, 2024 | Q4 2023 | -$0.32Est: -$0.31 | -3.2% | - | — | 10-K/A |
| Nov 13, 2023 | Q3 2023 | -$0.35Est: -$0.38 | +7.9% | - | — | — |
| Aug 10, 2023 | Q2 2023 | -$0.37Est: -$0.39 | +5.1% | - | — | — |
| May 11, 2023 | Q1 2023 | -$0.35Est: -$0.40 | +12.5% | $1.0M | — | — |